Key result
FDG PET guides assessment of myocardial viability, inflammatory cardiomyopathies, and prosthetic valve endocarditis.
Why the study?
PET imaging is increasingly used in cardiac patients for assessing myocardial viability, inflammatory cardiomyopathies, and endocarditis, but comprehensive guidance on protocols and interpretation is needed.
FDG PET imaging provides critical diagnostic and prognostic information for myocardial viability, inflammatory cardiomyopathies, and endocarditis.
No takes yet. Share an insight, caveat, or question.
PET supports assessment of viability and cardiac sarcoidosis; leaves open protocol standardization and prospective outcome trials.
Khalaf et al. (2020) conducted a review in Cardiac patients, particularly those with inflammatory cardiomyopathies such as sarcoidosis. Fluorodeoxyglucose positron emission tomography (PET) was evaluated. Fluorodeoxyglucose PET imaging plays a key role in assessing myocardial viability, inflammatory cardiomyopathies such as sarcoidosis, and prosthetic valve endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: